Krs Capital Management, LLC Reata Pharmaceuticals Inc Transaction History

Krs Capital Management, LLC

  • $137 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023
SELL
$79.22 - $105.37 $15,844 - $21,074
-200 Reduced 0.71%
27,941 $2.85 Million
Q1 2022

Apr 27, 2022
SELL
$24.12 - $39.6 $113,364 - $186,120
-4,700 Reduced 14.31%
28,141 $921,000
Q4 2021

Feb 11, 2022
BUY
$25.61 - $110.96 $841,058 - $3.64 Million
32,841 New
32,841 $866,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email